Prognostic Indicators for Surgical Patients Under 45 with Colorectal Liver Metastases

Overview

This study analyzes prognostic factors affecting disease-specific survival in surgical patients under 45 years with colorectal liver metastases (CRLM) compared to older patients.

Background

The incidence of colorectal cancer (CRC) in patients under 50 has increased, leading to a higher likelihood of metastatic disease at diagnosis. Surgical resection remains a potentially curative option for isolated liver metastases, yet the prognostic factors specific to younger patients are not well-defined.

Data Highlights

Key Findings

• Younger patients (< 45 years) had a median overall survival of 61 months compared to 49 months for older patients (≥ 45 years).
• 5-year overall survival was 51.4% for younger patients versus 41.4% for older patients.
• The younger cohort exhibited a higher proportion of advanced nodal disease (44% N2) compared to older patients (34% N2).
• There was no significant difference in demographics or tumor factors between the two age groups.
• Younger patients were more likely to receive perioperative chemotherapy, while older patients were more likely to have adjuvant chemotherapy.

Clinical Implications

The findings suggest that younger patients with CRLM may have better overall survival despite presenting with more advanced disease. This information could inform surgical decision-making and the management of treatment protocols for younger patients.

Conclusion

The study underscores the importance of evaluating age-specific prognostic factors in patients with colorectal liver metastases to enhance treatment strategies and outcomes.

Related Resources & Content

1. Updates in Surgery, 2026 -- CT-based radiomics improves survival prediction in colorectal liver metastases: beyond clinical scores
2. The ASCO Post, 2019 -- Meta-Analysis of Overall Survival With Laparoscopic vs Open Resection for Colorectal Liver Metastases
3. Updates in Surgery, 2024 -- Outcomes of Stage IV Primary Colon Cancer Resection with and without Concurrent Liver Metastasis Resection: A Propensity-Score Matched Analysis
4. A New Nomogram for Predicting Early Mortality in Patients with Resected Synchronous Multiple Primary Colorectal Cancer Utilizing SEER Data
5. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
6. Systematic Review and Meta-Analysis of Resection Sequence in Synchronous Colorectal Liver Metastasis: Primary vs. Liver First
7. Surgery for bilobar colorectal liver metastasis: from staged resections to liver transplantation. A systematic review of the outcomes of the different strategies - ScienceDirect
8. [Guideline for diagnosis and comprehensive treatment of colorectal liver metastases (version 2025)] - PubMed
9. Prognostic impact of tumour burden score on colorectal cancer liver metastasis survival following resection: a meta-analysis | Clinical and Translational Oncology | Springer Nature Link
10. Prognostic Preoperative Factors in Surgical Patients with Colorectal Liver Metastases: A Nationwide Multicenter Study
11. Circulating Tumor DNA as a Biomarker for Recurrence After Curative Resection of Colorectal Cancer Liver Metastases: A Systematic Review and Meta-Analysis - PubMed
12. Long-term Outcomes After Resection of Solitary Colorectal Liver Metastases - PubMed
13. Prognostic Factors in Colorectal Liver Metastases: An Exhaustive Review of the Literature and Future Prospectives - PubMed
14. Clinicopathologic characteristics, genomic signatures, and outcomes of patients undergoing resection for early- versus late-onset colorectal liver metastasis - PubMed
15. A comparison of overall survival from early-onset and late-onset colorectal cancer stratified by TNM stage: a systematic review | British Journal of Cancer
16. The Impact of Surgical Resection in Early Onset Colorectal Cancer Patients With Liver Limited Disease - PubMed